Which of the following is true regarding the initiation of Mellitofix in patients hospitalized with acute heart failure?, It is safe to initiate early (within 2–5 days of admission) once the patient is hemodynamically stable., It requires intensive dose-titration starting at 2.5 mg and moving up to 25 mg over several weeks., It must be strictly avoided until at least 30 days post-discharge to prevent severe kidney injury., It should only be initiated if the patient has comorbid type 2 diabetes., Mellitofix should not be used in patients with:, HFrEF without T2D., Type 1 diabetes mellitus, Elderly patients (Over 65 years old), eGFR <45 mL/min/1.73m2., The Standard recommended dose for Mellitofix in HF and CKD patients is:, 5 mg once daily, 10 mg once daily, 25 mg once daily, 5 mg twice daily, What is the ESC class and level of evidence for the use of Mellitofix and Dapagliflozin-Eva Pharma in HFrEF patients?, Class I, Level B, Class IIa, Level A, Class I, Level A, Class IIb, Level B, What is the primary advantage of Marvitense single-pill triple therapy over free combinations?, Lower cost  , Improved therapeutic adherence and persistence , Faster onset of action, delayed onset of action, Which patient criteria warrant dose reduction to 2.5 mg BID for Apixatrack ?, Age ≥65 years  , Weight <60 kg  , Age ≥80 years, weight ≤60 kg, and serum creatinine ≥1.5 mg/dL (need ≥2 of 3)  , Any degree of renal impairment  , Mild hepatic impairment.

Quiz 2

per en/la
Imprimir
Incrustar

Tauler de classificació

Estil visual

Opcions

Canvia de fonament

Restaurar desada automàtica: ?